# ADCT: ADC Therapeutics SA

- Industry: Pharmaceutical Preparations
- Current price: $1.05
- Price updated: Sep 19, 2026
- Total congressional trades: 1
- Politicians trading: 1
- Last traded: Feb 20, 2025
- Source: https://tryglasshouse.ai/companies/ADCT.md

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

# Congressional trading history

- Page: 1 of 1
- Results: 1 of 1
- Pagination query parameter: `page`

## 1. Ashley Moody

- Member: Republican, Senate
- Transaction: Sell, $1,001 - $15,000
- Dates: traded Feb 20, 2025, disclosed Mar 22, 2025
- Market context: $1.67 at trade, $1.05 current (-37.13%)
- Politician: https://tryglasshouse.ai/politicians/M001244.md
- Record: https://tryglasshouse.ai/trades/47a862e1-1140-4787-9d28-d7f874a1d938.md



Prices and percentage changes are market context, not portfolio returns. This information is not financial advice.